US to name for pause on Johnson & Johnson’s COVID-19 vaccine: NYT


April 13 

US federal health agencies on Tuesday will call for an immediate pause in use of Johnson & Johnson’s single-dose COVID-19 vaccine after six US recipients developed a rare disorder involving blood clots, the New York Times reported, citing officials briefed on the decision.



Be the first to comment on "US to name for pause on Johnson & Johnson’s COVID-19 vaccine: NYT"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: